The National Medical Commission (NMC) faced criticism after overruling the Supreme Court’s decision and its own commitment to accept patient appeals. In a controversial move, the Ethics and Medical Registration Board rejected a patient’s appeal in February 2023, despite the NMC’s promise to entertain such appeals back in September 2022. What raised eyebrows was the fact that the EMRB, responsible for this rejection, currently has vacant positions, casting doubts on the legitimacy of the decision-making process. This rejection seemed to mirror a similar denial issued in 2022, further fueling concerns about the transparency and fairness of the board’s actions. The incident has sparked debates within the medical community and among patient advocacy groups, highlighting the need for accountability and adherence to established protocols in such crucial matters. The NMC’s decision to go against its own guidelines and reject a patient’s appeal has raised questions about the autonomy and integrity of the regulatory body. With growing calls for greater oversight and transparency in the healthcare system, this development serves as a reminder of the importance of upholding ethical standards and ensuring justice for all stakeholders involved.